Bausch Health
BHC
$8.71
Share price
1.04%
Change (1 day)
18.18%
Change (1 year)
Categories
Bausch Health is a Canadian company that researches, develops and produces pharmaceuticals and markets patented drugs, generics and non-prescription drugs in the areas of dermatology and ophthalmology.
Bausch Health (BHC) - P/B ratio
P/B ratio as of April 2024 : -38.9
According to Bausch Health
's latest financial reports the company has a price-to-book ratio of -38.9.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Bausch Health - P/B ratio (from 2001 to 2023)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2023-12-31 | -35.8 | -508.55% |
| 2022-12-31 | 8.77 | -103.03% |
| 2021-12-31 | -290 | -2482.1% |
| 2020-12-31 | 12.2 | 31.65% |
| 2019-12-31 | 9.24 | 300.81% |
| 2018-12-31 | 2.30 | 88.45% |
| 2017-12-31 | 1.22 | -20.66% |
| 2016-12-31 | 1.54 | -73.25% |
| 2015-12-31 | 5.76 | -35.05% |
| 2014-12-31 | 8.87 | 19.09% |
| 2013-12-31 | 7.45 | 52.76% |
| 2012-12-31 | 4.88 | 33.29% |
| 2011-12-31 | 3.66 | 110.06% |
| 2010-12-31 | 1.74 | 6.26% |
| 2009-12-31 | 1.64 | 31.7% |
| 2008-12-31 | 1.24 | -25.49% |
| 2007-12-31 | 1.67 | -35.94% |
| 2006-12-31 | 2.61 | -15.99% |
| 2005-12-31 | 3.10 | 24.14% |
| 2004-12-31 | 2.50 | -7.2% |
| 2003-12-31 | 2.69 | -45.45% |
| 2002-12-31 | 4.94 |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 OPKO Health
OPK | 0.6322 | -101.62% | 🇺🇸 USA |
 Onconova Therapeutics ONTX | 1.44 | -103.70% | 🇺🇸 USA |